Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
Prevalence of cancer survivors in the United States
2024 Standout
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Works of Deme Karikios being referenced
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in
2020
Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Deme Karikios | 278 | 119 | 273 | 50 | 617 | |
| Megan E.V. Caram | 193 | 110 | 243 | 72 | 551 | |
| Jaclyn Beca | 265 | 239 | 190 | 56 | 635 | |
| Reith Sarkar | 251 | 70 | 266 | 44 | 607 | |
| Clarissa Mathias | 393 | 52 | 148 | 29 | 717 | |
| Hala T. Borno | 286 | 146 | 163 | 71 | 689 | |
| Laura H. Hendrix | 305 | 146 | 267 | 39 | 711 | |
| Peh Joo Ho | 377 | 59 | 108 | 39 | 637 | |
| Markus K. Schuler | 270 | 37 | 258 | 60 | 549 | |
| Yichen Zhang | 191 | 131 | 250 | 48 | 605 | |
| Jinani Jayasekera | 319 | 88 | 202 | 55 | 563 |
All Works
Login with ORCID to disown or claim papers
Loading papers...